NasdaqCM - Delayed Quote USD

Nutex Health Inc. (NUTX)

Compare
18.50 -0.17 (-0.91%)
At close: 4:00 PM EDT
Loading Chart for NUTX
DELL
  • Previous Close 18.67
  • Open 18.66
  • Bid 18.21 x 100
  • Ask 19.23 x 100
  • Day's Range 17.51 - 19.02
  • 52 Week Range 4.16 - 45.00
  • Volume 93,744
  • Avg. Volume 72,720
  • Market Cap (intraday) 93.716M
  • Beta (5Y Monthly) 1.82
  • PE Ratio (TTM) --
  • EPS (TTM) -8.67
  • Earnings Date Nov 7, 2024 - Nov 11, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 45.00

Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.

www.nutexhealth.com

800

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NUTX

View More

Performance Overview: NUTX

Trailing total returns as of 9/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NUTX
31.48%
S&P 500
20.45%

1-Year Return

NUTX
35.09%
S&P 500
32.46%

3-Year Return

NUTX
98.82%
S&P 500
25.37%

5-Year Return

NUTX
98.82%
S&P 500
25.37%

Compare To: NUTX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NUTX

View More

Valuation Measures

Annual
As of 9/25/2024
  • Market Cap

    94.58M

  • Enterprise Value

    342.39M

  • Trailing P/E

    0.84

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.32

  • Price/Book (mrq)

    1.51

  • Enterprise Value/Revenue

    1.24

  • Enterprise Value/EBITDA

    82.37

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -13.73%

  • Return on Assets (ttm)

    2.43%

  • Return on Equity (ttm)

    -31.29%

  • Revenue (ttm)

    275.93M

  • Net Income Avi to Common (ttm)

    -37.89M

  • Diluted EPS (ttm)

    -8.67

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    40.81M

  • Total Debt/Equity (mrq)

    351.88%

  • Levered Free Cash Flow (ttm)

    16.82M

Research Analysis: NUTX

View More

Company Insights: NUTX

Research Reports: NUTX

View More

People Also Watch